Last mentioned: Mar 26, 2026
A nationwide recall has been issued for alcohol pads due to life-threatening bacterial contamination, forcing major retailers and e-commerce platforms to halt sales immediately. The recall highlights critical vulnerabilities in the medical supply chain and the challenges of managing reverse logistics for contaminated antiseptic products.
The FDA has initiated a nationwide recall of nearly 90,000 bottles of children's ibuprofen, forcing major retailers and e-commerce platforms to purge inventory. This large-scale safety action highlights critical vulnerabilities in pediatric pharmaceutical supply chains and consumer trust.
A widespread recall has been issued for a wellness supplement after testing revealed the presence of Sildenafil, the active pharmaceutical ingredient in Viagra. This discovery poses severe health risks to consumers with underlying conditions and underscores the persistent challenges of regulatory oversight in the online supplement market.
Amai Proteins has achieved a major regulatory milestone with the U.S. FDA’s GRAS approval for Sweelin, its designer protein sweetener. This clearance allows for the immediate integration of the sugar alternative into the U.S. food and beverage supply chain, targeting a $100 billion sugar-reduction market.
This page surfaces every story mentioning FDA across our retail coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running retail beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where FDA was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |